CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(05): E693-E698
DOI: 10.1055/a-1374-5839
Original article

Severe upper gastrointestinal bleeding is halted by endoscopically delivered self-propelling thrombin powder: A porcine pilot study

Nabil Ali-Mohamad
1   The University of British Columbia – Michael Smith Laboratories, Vancouver, British Columbia, Canada
,
Massimo Cau
1   The University of British Columbia – Michael Smith Laboratories, Vancouver, British Columbia, Canada
3   The University of British Columbia – School of Biomedical Engineering, Vancouver, British Columbia, Canada
,
James Baylis
1   The University of British Columbia – Michael Smith Laboratories, Vancouver, British Columbia, Canada
3   The University of British Columbia – School of Biomedical Engineering, Vancouver, British Columbia, Canada
,
Veronika Zenova
1   The University of British Columbia – Michael Smith Laboratories, Vancouver, British Columbia, Canada
,
Hugh Semple
4   Defense Research and Development Canada Suffield Research Centre – Suffield Research Centre, Medicine Hat, Alberta, Canada
,
Andrew Beckett
5   University of Toronto Faculty of Medicine – Department of Surgery, Toronto, Ontario, Canada
,
Andrew McFadden
6   The University of British Columbia Faculty of Medicine – Department of Surgery, Vancouver, British Columbia, Canada
,
Fergal Donnellan
7   The University of British Columbia Faculty of Medicine – Division of Gastroenterology, Vancouver, British Columbia, Canada
,
Christian Kastrup
1   The University of British Columbia – Michael Smith Laboratories, Vancouver, British Columbia, Canada
2   The University of British Columbia Faculty of Medicine, Department of Biochemistry and Molecular Biology, Vancouver, British Columbia, Canada
› Institutsangaben

Abstract

Background and study aims Hemostatic powders have emerged recently to treat upper gastrointestinal bleeding (UGIB). Previously, we developed a novel self-propelling thrombin powder (SPTP) that effectively manages external pulsatile arterial bleed without compression, by effervescing and carrying thrombin into the wound. Here, we tested if SPTP, sprayed endoscopically, can manage severe UGIB in a live porcine model.

Materials and methods Anesthetized pigs underwent laparotomy to insert the gastroepiploic vascular bundles into the stomach lumen via a gastrotomy. Bleeding was initiated endoscopically in the stomach by needle knife. SPTP was delivered to the site of bleeding from a CO2-powered spray device using a 7 FR catheter. Successful primary hemostasis, time to hemostasis, and the mass of SPTP delivered were measured.

Results Hemostasis was achieved at all bleeding sites using SPTP. Mean time to hemostasis was 4.2 ± 0.9 minutes (mean ± standard error of the mean, n = 12). The average mass of SPTP delivered was 2.4 ± 0.6 g.

Conclusions In this pilot study, SPTP successfully stopped 12 cases of severe UGIB, demonstrating early promise asa novel hemostatic powder.



Publikationsverlauf

Eingereicht: 27. November 2020

Angenommen: 22. Januar 2021

Artikel online veröffentlicht:
22. April 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Jairath V, Hearnshaw S, Brunskill SJ. et al. Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev 2010;
  • 2 Gupta PK, Fleischer DE. Nonvariceal upper gastrointestinal bleeding. Med Clin North Am 1993; 77: 973-992
  • 3 Giday SA, Kim Y, Krishnamurty DM. et al. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy 2011;
  • 4 Kaehler G, Dutenhoefner C, Magdeburg R. Endoscopic application of polysaccharide powder for hemostasis in anticoagulated pigs (with video). Gastrointest Endosc 2015; 82: 161-163
  • 5 Wong Kee Song LM, Levy MJ. Emerging endoscopic therapies for nonvariceal upper gastrointestinal bleeding. Gastroenterol Clin North Am 2014; 43: 721-737
  • 6 Shahidi N, Enns R. Hemostatic sprays to control active nonvariceal upper gastrointestinal bleeding. Tech Gastrointest Endosc 2016;
  • 7 Cahyadi O, Bauder M, Meier B. et al. Effectiveness of TC-325 (Hemospray) for treatment of diffuse or refractory upper gastrointestinal bleeding - a single center experience. Endosc Int Open 2017;
  • 8 Gralnek IM, Dumonceau JM, Kuipers EJ. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: a1-a46
  • 9 Nelms DW, Pelaez CA. The acute upper gastrointestinal bleed. Surg Clin North Am 2018;
  • 10 Baylis JR, St JohnAE, Wang X. et al. Self-propelled dressings containing thrombin and tranexamic acid improve short-term survival in a swine model of lethal junctional hemorrhage. Shock 2016;
  • 11 Baylis JR, Yeon JH, Thomson MH. et al. Self-propelled particles that transport cargo through flowing blood and halt hemorrhage. Sci Adv 2015;
  • 12 Baylis JR, Lee MM, St John AE. et al. Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self-propelling particles. J Thromb Haemost 2019; 17: 1645-1654
  • 13 Baylis JR, Finkelstein-Kulka A, Macias-Valle L. et al. Rapid hemostasis in a sheep model using particles that propel thrombin and tranexamic acid. Laryngoscope 2017; 127: 787-793
  • 14 Sung JJY, Luo D, Wu JCY. et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011;
  • 15 Holster IL, Kuipers EJ, Tjwa ETTL. Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy 2013;
  • 16 Leblanc S, Vienne A, Dhooge M. et al. Early experience with a novel hemostatic powder used to treat upper GI bleeding related to malignancies or after therapeutic interventions (with videos). Gastrointest Endosc 2013;
  • 17 Yau AHL, Ou G, Galorport C. et al. Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. Can J Gastroenterol Hepatol 2014;
  • 18 Law R, Cardenas A. Hemostatic Powder for Gastrointestinal Bleeding: Time to believe the hype or more false hope?. Dig Liver Dis 2020; 52: 702-703
  • 19 Rodríguez de Santiago E, Burgos-Santamaria D, Pérez-Carazo L. et al. Hemostatic spray powder TC-325 for GI bleeding in a nationwide study: survival and predictors of failure via competing risks analysis. Gastrointest Endosc 2019;
  • 20 Vitali F, Naegel A, Atreya R. et al. Comparison of Hemospray® and EndoclotTM for the treatment of gastrointestinal bleeding. World J Gastroenterol 2019; 25: 1592-1602
  • 21 Chahal D, Lee JGH, Ali-Mohamad N. et al. High rate of re-bleeding after application of Hemospray for upper and lower gastrointestinal bleeds. Dig Liver Dis 2020;
  • 22 Forrest JAH, Finlayson NDC, Shearman DJC. Endoscopy in gastrointestinal bleeding. Lancet 1974; 304: 394-397
  • 23 Giday S, Van Alstine W, Van Vleet J. et al. Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding. Dig Dis Sci 2013; 58: 3422-3428
  • 24 Macrae FL, Duval C, Papareddy P. et al. A fibrin biofilm covers blood clots and protects from microbial invasion. J Clin Invest 2018;
  • 25 Eckmann DM, Diamond SL. Surfactants attenuate gas embolism-induced thrombin production. Anesthesiology 2004;
  • 26 Pittayanon R, Prueksapanich P, Rerknimitr R. The efficacy of Hemospray in patients with upper gastrointestinal bleeding from tumor. Endosc Int Open 2016;
  • 27 Pittayanon R, Rerknimitr R, Barkun A. Prognostic factors affecting outcomes in patients with malignant GI bleeding treated with a novel endoscopically delivered hemostatic powder. Gastrointest Endosc 2018;
  • 28 Vreeburg EM, Levi M, Rauws EAJ. et al. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther 2001;
  • 29 Poller L. Fibrinolysis and gastrointestinal haemorrhage. J Clin Pathol 1980;